Via Dr. Ken Pope’s mail list, this news release from the AMA:
Two essential elements of medical practice—patient privacy and the patient-physician relationship—are at stake in a case before a federal appeals court that involves a state prescription drug monitoring program (PDMP) and surveillance by the U.S. Drug Enforcement Administration (DEA).
The issue in question is whether the DEA as a law enforcement agency has the right to access sensitive patient data without probable cause. PDMPs collect patient prescription data to be used by doctors and pharmacists for responsible treatment and prescription practices. Allowing unfettered access to such information could dramatically affect physicians’ ability to prescribe the medications their patients need and limit the role of the PDMP to allow physicians to identify other prescriptions the patient has had which can enable more informed decisions about the patient’s medical needs.
In this case, a federal magistrate judge ruled the DEA could enforce a subpoena against the Oregon PDMP that allowed disclosure of protected health information without patients’ informed consent. The Litigation Center of the AMA and State Medical Societies and the Oregon Medical Association earlier this month filed an amicus brief in support of the Oregon PDMP and the American Civil Liberties Union of Oregon, which intervened in the case.
[…]
Visit the AMA Litigation Center’s Web page to learn more about this case and others related to patient privacy.